Products

Sandoo magnum est Ketorolac Trometamolum, Hydrochloridum Olopatadinum, Vancomycin hydrochloridum artifices et praebitores in Sinis. Nostra officina in API, anti-cancro, antivirali medicamento media, subtilia chemicis, cibariis additivis export et plus quam X annos importat, positi sunt, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniae Regnum. Gallia, etc., et paulatim plus XX regionibus circum orbem terrarum tegunt.
View as  
 
2-TRIFLUOROMETHYL-4-CHLOROPYRIDINE

2-TRIFLUOROMETHYL-4-CHLOROPYRIDINE

Product Name:2-TRIFLUOROMETHYL-4-CHLOROPYRIDINE
Formulae hypotheticae: C6H3ClF3N
Molecular pondus:181.54
CAS Subcriptio Number:131748-146

Lege plusMitte Inquisitionem
2-Chloro-4-(trifluoromethyl)pyridine

2-Chloro-4-(trifluoromethyl)pyridine

Product Name:2-Chloro-4-(trifluoromethyl)pyridine
Formulae hypotheticae: C6H3ClF3N
Molecular pondus:181.54
CAS Subcriptio Number:81565-18-6

Lege plusMitte Inquisitionem
2-Amino-6-(trifluoromethyl)pyridine

2-Amino-6-(trifluoromethyl)pyridine

Product Name:2-Amino-6-(trifluoromethyl)pyridine
Formulae hypotheticae: C6H5F3N2
Molecular pondus:162.11
CAS Subcriptio Number:34486-24-3

Lege plusMitte Inquisitionem
5-(Trifluoromethyl) pyridin-2-amine

5-(Trifluoromethyl) pyridin-2-amine

Product Name:5-(Trifluoromethyl) pyridin-2-amine
Formulae hypotheticae: C6H5F3N2
Molecular pondus:162.11
CAS Subcriptio Number: 74784-70-6

Lege plusMitte Inquisitionem
4-Amino-2-trifluoromethylpyridine

4-Amino-2-trifluoromethylpyridine

Product Name:4-Amino-2-trifluoromethylpyridine
Formulae hypotheticae: C6H5F3N2
Molecular pondus:162.11
CAS Subcriptio Number:147149-98-2

Lege plusMitte Inquisitionem
2-Amino-4-(trifluoromethyl)pyridine

2-Amino-4-(trifluoromethyl)pyridine

Product Name:2-Amino-4-(trifluoromethyl)pyridine
Formulae hypotheticae: C6H5F3N2
Molecular pondus:162.11
CAS Subcriptio Number:106447-97-6

Lege plusMitte Inquisitionem
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept